TOLAK (Pierre Fabre Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the TOLAK drug offered from Pierre Fabre Pharmaceuticals, Inc.. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Pierre Fabre Pharmaceuticals, Inc. |
| NON-PROPRIETARY NAME: | FLUOROURACIL |
| SUBSTANCE NAME: | FLUOROURACIL |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
| ROUTE: | TOPICAL |
| DOSAGE FORM: | CREAM |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2017-03-15 |
| END MARKETING DATE: | 0000-00-00 |
TOLAK HUMAN PRESCRIPTION DRUG Details:
| Item Description | TOLAK from Pierre Fabre Pharmaceuticals, Inc. |
| LABELER NAME: | Pierre Fabre Pharmaceuticals, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 40(mg/g) |
| START MARKETING DATE: | 2017-03-15 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 64370-421_829a580c-1d01-4c37-96a6-d7c4ce27bfa5 |
| PRODUCT NDC: | 64370-421 |
| APPLICATION NUMBER: | NDA022259 |
Other FLUOROURACIL Pharmaceutical Manufacturers / Labelers:
